Download App

Log in to access Online Inquiry
Company Overview More
Shenzhen Hypri Pharmaceutical Group Co., Ltd. is a Chinese pharmaceutical company with business in heparin sodium preparation and API, macromolecular drug contract development and production organization (CDMO) and innovative drug development. The company's main products and services include enoxaparin sodium preparations and heparin sodium raw materials, enoxaparin sodium raw materials, and macromolecular drug CDMO services. The company's products are sold in the domestic market and overseas markets, including Turkey, Brazil and the United States.
CEO: Li Li
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

09989 SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD.

6.290+0.160+2.61%
Market Close 05/23 16:08 CCT
High
6.500
Open
6.130
Turnover
25.57M
Low
6.130
Pre Close
6.130
Volume
4.05M
Market Cap
9.23B
P/E(TTM)
22.30
52wk High
11.600
Shares
1.47B
P/E(Static)
31.29
52wk Low
5.270
Float Cap
1.38B
Bid/Ask %
55.73%
Historical High
19.300
Shs Float
220.09M
Volume Ratio
1.94
Historical Low
5.270
Dividend TTM
0.18
Div Yield TTM
0.18
P/B
0.64
Dividend LFY
2.86%
Div Yield LFY
2.86%
Turnover Ratio
1.84%
Amplitude
6.04%
Avg Price
6.314
Lot Size
500
Float Cap
1.38B
Bid/Ask %
55.73%
Historical High
19.300
Shs Float
220.09M
Volume Ratio
1.94
Historical Low
5.270
Dividend TTM
0.18
P/B
0.64
Dividend LFY
2.86%
Turnover Ratio
1.84%
Amplitude
6.04%
Avg Price
6.314
Lot Size
500
Price Forecast

No Data

News

Comment